171
Participants
Start Date
January 25, 2023
Primary Completion Date
October 13, 2023
Study Completion Date
October 13, 2023
avelumab
as provided in real world practice
axitinib
as provided in real world practice
Nagoya University Hospital, Nagoya
Hirosaki University Hospital, Hirosaki
Kurume University Hospital, Kurume-shi
Asahikawa Medical University Hospital, Asahikawa
Sapporo Medical University Hospital, Sapporo
Kobe University Hospital, Kobe
Kobe City Medical Center General Hospital, Kobe
Kanazawa University Hospital, Kanazawa
Kochi Medical School Hospital, Nankoku
National Hospital Organization Kyoto Medical Center, Kyoto
Kindai University Hospital, Sayama
Osaka University Hospital, Suita
Jichi Medical University Saitama Medical Center, Saitama
Keio University Hospital, Shinjuku-ku
Wakayama Medical University Hospital, Wakayama
Yamagata University Hospital, Yamagata
Kyushu University Hospital, Fukuoka
Hiroshima University Hospital, Hiroshima
University Hospital Kyoto Prefectural University of Medicine, Kyoto
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
INDUSTRY